Literature DB >> 35178538

A Comprehensive Review of Management of Colorectal Liver Mets in the Current Era.

Hassan Aziz1, Zubair Ahmed2, Yi Lee2, Gavin Drumm3, Muhammad Wasif Saif4.   

Abstract

Colorectal carcinoma is the third most common cancer in the US. The liver tends to be the most common site of metastasis. This review provides an in-depth analysis of non-transplant options available in the management of colorectal liver mets.

Entities:  

Keywords:  Cancer; Colorectal carcinoma; Liver mets

Year:  2021        PMID： 35178538      PMCID： PMC8849579     

Source DB:  PubMed          Journal:  Cancer Med J


  59 in total

Review 1.  Literature Review of Current Management of Colorectal Liver Metastasis.

Authors:  Diana Mitchell; Yana Puckett; Quang N Nguyen
Journal:  Cureus       Date:  2019-01-23

2.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Murielle Mauer; Erik Tanis; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2013-10-11       Impact factor: 41.316

Review 3.  Metastatic colorectal cancer: from improved survival to potential cure.

Authors:  David J Gallagher; Nancy Kemeny
Journal:  Oncology       Date:  2010-06-04       Impact factor: 2.935

4.  Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Authors:  Linda M Pak; Nancy E Kemeny; Marinela Capanu; Joanne F Chou; Taryn Boucher; Andrea Cercek; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; Michael I D'Angelica
Journal:  J Surg Oncol       Date:  2017-11-22       Impact factor: 3.454

5.  Selection for hepatic resection of colorectal liver metastases: expert consensus statement.

Authors:  Reid B Adams; Thomas A Aloia; Evelyne Loyer; Timothy M Pawlik; Bachir Taouli; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

6.  Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases.

Authors:  Peter J Allen; Aviram Nissan; Antonio I Picon; Nancy Kemeny; Paul Dudrick; Leah Ben-Porat; Joseph Espat; Alexander Stojadinovic; Alfred M Cohen; Yuman Fong; Philip B Paty
Journal:  J Am Coll Surg       Date:  2005-07       Impact factor: 6.113

7.  Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial.

Authors:  Wentao Tang; Li Ren; Tianshu Liu; Qinghai Ye; Ye Wei; Guodong He; Qi Lin; Xiaoying Wang; Mingliang Wang; Fei Liang; Yuehong Cui; Jianmin Xu
Journal:  J Clin Oncol       Date:  2020-08-04       Impact factor: 44.544

8.  A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.

Authors:  J Randolph Hecht; Edith Mitchell; Tarek Chidiac; Carroll Scroggin; Christopher Hagenstad; David Spigel; John Marshall; Allen Cohn; David McCollum; Philip Stella; Robert Deeter; Seta Shahin; Rafael G Amado
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

9.  Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; Erika Hitre; Jerzy Zaluski; Chung-Rong Chang Chien; Anatoly Makhson; Geert D'Haens; Tamás Pintér; Robert Lim; György Bodoky; Jae Kyung Roh; Gunnar Folprecht; Paul Ruff; Christopher Stroh; Sabine Tejpar; Michael Schlichting; Johannes Nippgen; Philippe Rougier
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

Review 10.  The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.

Authors:  Stéphane Benoist; Bernard Nordlinger
Journal:  Ann Surg Oncol       Date:  2009-06-25       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.